Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis.
Rastogi
N
N
Unité de la Tuberculose et des Mycobactéries, Institut Pasteur de la Guadeloupe, Pointe-à-Pitre, Guadeloupe, French West Indies.
Goh
K S
KS
Van Ginkel
S Z
SZ
Wright
E L
EL
Barrow
W W
WW
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D002569:Cerulenin / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D002934:Cinnamates / Q000494:pharmacology*; D004359:Drug Therapy, Combination / Q000494:pharmacology; D066298:In Vitro Techniques; D015269:Mycobacterium avium Complex / Q000187:drug effects* / Q000378:metabolism; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012150:Polymorphism, Restriction Fragment Length; D011874:Radiometry; D010135:p-Fluorophenylalanine / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000935:Antifungal Agents; D002934:Cinnamates; C029010:cinnamic acid; D002569:Cerulenin; D010135:p-Fluorophenylalanine